Drug Type Liposomal Drug |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC44H86N4O3 |
InChIKeyNORPURPOULJLIG-UHFFFAOYSA-N |
CAS Registry2991244-19-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Splenic Diseases | Preclinical | China | 01 Jan 2025 | |
| Splenic Diseases | Preclinical | China | 01 Jan 2025 |





